News ItemBIO Report on Emerging Therapeutic Company Investment and Deal Trends

September 13, 2015 – 

This report was developed by David Thomas, CFA and Chad Wessel, BIO INDUSTRY ANALYSIS. 

The information will help inform our future policy work and provide industry, policymakers, and other stakeholders with a comprehensive view of the investment and partnering environment for novel therapeutics.  To view report please click link below.

BIO Emerging Therapeutic Company Report June 11 2015

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

AMRI

AMRI

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio